FDA Approves Summit's Ophthalmic Excimer Laser

The US Food and Drug Administration (FDA) recently gave Summit Technology Inc. of Waltham, Mass., approval to market the SVS Apex Plus excimer laser system for the treatment of mild to moderate nearsightedness, corneal scars and disorders, and dystrophies. The company says Apex systems can be upgraded to the Plus version in three days. Summit is seeking FDA approval to use Apex Plus for astigmatism and hyperopia.





LATEST NEWS

• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024
• One-Step Hologram Generation Speeds 3D Display Creation
  Apr 24, 2024
• Innovation Award Winners for Laser Technology Honored in Aachen
  Apr 23, 2024
• Intech 2024: AI Arrives on the Shop Floor
  Apr 22, 2024